Azithromycin is currently available and the U.S. Food and Drug Administration (FDA) moved it to a resolved shortage status on December 30, 2020. Please notify your local health department of any challenges in procuring product. For more information on the availability of Azithromycin see the FDA Drug Shortages websiteexternal icon.
The Food and Drug Administration (FDA) reported a shortage of azithromycin tablets on 4/14/2020. Azithromycin is the recommended treatment for chlamydia, nongonococcal urethritis, and cervicitis. It is also used in the recommended dual therapy for gonorrhea. Alternative regimens for chlamydia, nongonococcal urethritis, and cervicitis are outlined in the 2021 STI Treatment Guidelines. Temporary alternative regimens for gonorrhea, in addition to syndromes for which empiric gonorrhea treatment is indicated, are addressed in the guidance on STD treatment during the COVID19 pandemicpdf icon. Product is available or in limited supply from some manufacturers. For more information regarding the availability of azithromycin, visit the FDA Drug Shortage Websiteexternal icon.